Product and method for producing an immune system supplement and performance enhancer
IPC분류정보
국가/구분
United States(US) Patent
등록
국제특허분류(IPC7판)
A61K-033/20
A61K-033/40
A61K-033/14
A01N-059/08
출원번호
US-0592402
(2009-11-24)
등록번호
US-8455010
(2013-06-04)
발명자
/ 주소
Norton, Verdis
Samuelson, Gary L.
출원인 / 주소
Reoxcyn Discoveries Group, Inc
대리인 / 주소
K&L Gates LLP
인용정보
피인용 횟수 :
9인용 특허 :
72
초록▼
A balanced redox-signaling compound with reactive molecules that mimic those naturally occurring inside cells that have been precisely stabilized and formulated as a supplement for oral consumption acting to enhance proper immune system function, enhance the efficiency and production of the body's n
A balanced redox-signaling compound with reactive molecules that mimic those naturally occurring inside cells that have been precisely stabilized and formulated as a supplement for oral consumption acting to enhance proper immune system function, enhance the efficiency and production of the body's native antioxidants as well as enhance the performance of intercellular communications involved in healthy tissue maintenance and athletic performance.
대표청구항▼
1. A method for producing a balanced foundational redox-signaling oral (RSO) compound to enhance the efficiency and production of the body's native antioxidants and the performance of intercellular communications involved in the maintenance of healthy tissues and athletic performance, comprising: a.
1. A method for producing a balanced foundational redox-signaling oral (RSO) compound to enhance the efficiency and production of the body's native antioxidants and the performance of intercellular communications involved in the maintenance of healthy tissues and athletic performance, comprising: a. determining a balanced target mixture of chemical redox-signaling molecules for healthy cells and measuring concentrations of reactive molecules present using a combination of R-Phycoerythrin (R-PE), Aminophenyl Fluorescein (APF) and Hydroxyphenyl Fluorescein (HPF),b. electrochemically replicating this target mixture by:i. mixing an initial circulating saline solution,ii. adjusting the temperature, flow and sodium chloride concentration of the circulating saline solution at a level to prevent production of chlorates and regulate relative concentrations of resulting reactive molecules,iii. activating an electrochemical device to oxidize and reduce the circulating saline solution to produce a concentration and mixture of reactive molecules similar to those present in the target mixture by varying temperature, flow, pH, power-source modulation, salt homogeneity, and concentration parameters of the circulating saline solution to form an RSO compound, andc. verifying the similarity of the concentration of the redox-signaling molecules in the target mixture with those in the electrochemically replicated RSO compound to produce a verified RSO compound by using the combination of R-Phycoerythrin (R-PE), Aminophenyl Fluorescein (APF) and Hydroxyphenyl Fluorescein (HPF) used to measure the concentrations of reactive molecules present in the target mixture. 2. A method for producing a balanced foundational redox-signaling oral compound according to claim 1, wherein the combination of R-Phycoerythrin (R-PE), Aminophenyl Fluorescein (APF) and Hydroxyphenyl Fluorescein (HPF) is used for verification such that: i. a 2 micromolar concentration of R-PE loses 5%-50% of its fluorescence 6 hours after a 1:1000 solution of the RSO compound is added,ii. R-PE measurements indicate the same fluoroescence levels as a standard ROS generating solution of 0.2 or 1.0 mM AAPH,iii. APF measurements indicate the same relative amount as the target solution,iv. HPF measurements indicate a negligibly small reading,v. a pH of between 7.2 and 7.5, andvi. total chlorine concentration of less than 35 ppm by weight. 3. A method for producing a balanced foundational redox-signaling oral compound according to claim 1, including activating a fluid circulation device to maintain flow aging stratification and homogeneity of the circulating saline solution. 4. A method for producing a balanced foundational redox signaling oral compound according to claim 1, wherein the circulating saline solution has approximately 0.05% to 10% sodium chloride concentration by weight. 5. A method for producing a balanced foundational redox-signaling oral compound according to claim 1, wherein the combination of Aminophenyl fluorescein (APF) and Hydroxyphenyl fluorescein (HPF) is used for the detection of highly reactive oxygen species (hROS). 6. A method for enhancing an athletic performance characteristic, comprising: administering an RSO compound formed by activating an electrochemical device to oxidize and reduce a circulating saline solution to produce a concentration and mixture of reactive molecules similar to those present in a target mixture by varying temperature, flow, pH, power-source modulation, salt homogeneity, and concentration parameters of the circulating saline solution to form the RSO compound; andenhancing an athletic performance characteristic, wherein the method further comprises verifying the similarity of the concentration of the redox-signaling molecules in the target mixture with those in the RSO compound by analyzing measurements from a combination of R-Phycoerythrin (R-PE), Aminophenyl Fluorescein (APF) and Hydroxyphenyl Fluorescein (HPF) assays. 7. The method according to claim 6, wherein the measurements from the combination of R-Phycoerythrin (R-PE), Aminophenyl Fluorescein (APF) and Hydroxyphenyl Fluorescein (HPF) assays are used for verification such that: i. a 2 micromolar concentration of R-PE loses 5%-50% of its fluorescence 6 hours after a 1:1000 solution of the RSO compound is added,ii. R-PE measurements indicate the same fluoroescence levels as a standard ROS generating solution of 0.2 or 1.0 mM AAPH,iii. APF measurements indicate the same relative amount as the target solution,iv. HPF measurements indicate a negligibly small reading,v. a pH of between 7.2 and 7.5, andvi. total chlorine concentration of less than 35 ppm by weight. 8. The method according to claim 6, including activating a fluid circulation device to maintain flow aging stratification and homogeneity of the circulating saline solution. 9. The method according to claim 6, wherein the circulating saline solution has approximately 0.05% to 10% sodium chloride concentration by weight. 10. The method according to claim 6, wherein the combination of Aminophenyl fluorescein (APF) and Hydroxyphenyl fluorescein (HPF) is used for detection of highly reactive oxygen species (hROS). 11. The method according to claim 6, wherein the athletic performance characteristic is higher power output, longer time to ventilatory threshold, longer time to VO2max, or increased efficiency of cells during athletic performance.
Prasnikar Albert R. ; Carlson Richard C. ; Coin Richard J. ; Ernes Lynne M. ; Mitchell Thomas A. ; Lezan Catherine M., Electrode and electrolytic cell containing same.
Gram Helen F. (Los Alamos NM) Muller Martin E. (Los Alamos NM) Pendergrass Ann M. (Los Alamos NM) Rink Philip A. (Everett WA), Electrolytic method and cell for sterilizing water.
Hohmann Eugen (Bensheim DEX) Mund Konrad (Uttenreuth DEX) Weidlich Erhard (Spardorf DEX), Method and apparatus for cleaning, disinfecting and sterilizing medical instruments.
Ladha Kamal K. (Riverview MI) Herring William M. (Trenton MI) Louvar Joseph F. (Lincoln Park MI), Method and apparatus for purifying aqueous streams contaminated with organic materials.
van Duin Pieter J. (Noordwijk NLX) de Jong Antonius M. C. P. (Pijnacker NLX), Method for the electrolytic preparation of hypochlorite in flowing salt-containing water.
Patapoff Walter (1215 W. Camino Del Sur San Dimas CA 91773) Wong Jim Lung (638 Bowcreek Dr. Diamond Bar CA 91765), Miniaturized handheld desalination field unit.
Fife James F. (Seattle WA) Vorhis Daniel J. (Seattle WA) Laughlen Kenneth D. (Seattle WA) Dienes Nancy L. (Seattle WA), Portable water filter and valve assembly.
Van Wyk, Henk; Van Wyk, Mariette; Krebs, Trace; Lange, Peter; Denomme, Brian; Volk, Michael A., Compositions and methods for the prevention and treatment of cardiovascular diseases.
Van Wyk, Henk; Van Wyk, Mariette; Krebs, Trace; Lange, Peter; Denomme, Brian; Volk, Michael A., Compositions and methods for the prevention and treatment of cardiovascular diseases.
Van Wyk, Henk; Van Wyk, Mariette; Krebs, Trace; Lange, Peter; Denomme, Brian; Volk, Michael A., Compositions and methods for the prevention and treatment of cardiovascular diseases.
Van Wyk, Henk; Van Wyk, Mariette; Krebs, Trace; Lange, Peter; Denomme, Brian; Volk, Michael A., Compositions and methods for the prevention and treatment of cardiovascular diseases.
Norton, Verdis; Samuelson, Gary L., Method and apparatus for producing a stabilized antimicrobial non-toxic electrolyzed saline solution exhibiting potential as a therapeutic.
Norton, Verdis; Samuelson, Gary L., Method and apparatus for producing a stabilized antimicrobial non-toxic electrolyzed saline solution exhibiting potential as a therapeutic.
Lange, Peter; Denomme, Brian; Van Wyk, Henk; Van Wyk, Mariette; Krebs, Tracy L.; Ozgur, Sezgin; Haroon, Zishan, Methods of treating or ameliorating skin conditions with a magnetic dipole stabilized solution.
Lange, Peter; Denomme, Brian; Van Wyk, Henk; Van Wyk, Mariette; Krebs, Tracy L.; Ozgur, Sezgin; Haroon, Zishan, Methods of treating or ameliorating skin conditions with a magnetic dipole stabilized solution.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.